Medical Weight Loss
Compounded GLP-1 Medications
Compounded Semaglutide and Tirzepatide prescribed by licensed providers and prepared by FDA-registered pharmacies. Skip the waiting rooms and get medication delivered to your door.
.png&w=828&q=75)
Product image for illustration only. Medications are compounded by independent FDA-registered pharmacies, not by Fifty 410.
Choose Your Treatment
Both options are provider-prescribed and customized for you
Tirzepatide
Compounded GLP-1/GIP Receptor Agonist
- Dual GLP-1 and GIP receptor agonist
- Once weekly subcutaneous injection
- Personal compounded formula
- Provider-monitored dosing protocol
- Requires medical evaluation
Semaglutide
Compounded GLP-1 Receptor Agonist
- GLP-1 receptor agonist
- Once weekly subcutaneous injection
- Personal compounded formula
- Personalized dosing schedule
- Requires medical evaluation
About GLP-1 Medications
General information about this class of medications
GLP-1 Receptor Binding
GLP-1 agonists are designed to bind to GLP-1 receptors in the body. These receptors are found in areas of the brain involved in appetite regulation. Individual responses vary.
Gastric Motility
GLP-1 medications are known to affect the rate of gastric emptying. Your healthcare provider can explain how this may relate to your treatment plan.
Insulin Pathway
GLP-1 receptor agonists interact with insulin signaling pathways. They are used in the management of type 2 diabetes. Effects vary by individual.
Provider Guidance
Your prescribing provider will evaluate whether GLP-1 medication is appropriate for your situation and monitor your response to treatment.
Getting Started
Four steps to begin the evaluation process
Complete Assessment
Answer questions about your health history, weight goals, and current medications
Provider Review
A licensed provider evaluates your case and determines the right medication for you
Receive Medication
Your personalized GLP-1 medication ships free to your door in 1-2 days
Track Progress
Ongoing provider support with dosage adjustments as you progress
Frequently Asked Questions
Everything you need to know about GLP-1 treatment
What should I expect from treatment?
Individual responses to GLP-1 medications vary significantly based on many factors including genetics, adherence, lifestyle, and overall health. Your provider will discuss realistic expectations based on your specific medical history. No specific outcomes can be guaranteed.
What are compounded GLP-1 medications?
Drug compounding is the practice of creating customized medications by pharmacies to meet individual patient needs. Our medications are prepared by FDA-registered 503A and 503B compounding pharmacies, which are subject to federal and state regulatory oversight. Important: Compounded medications are NOT FDA-approved finished drug products and have not undergone FDA review for safety, efficacy, or quality.
What are the potential side effects?
Common side effects include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation. More serious side effects are possible and include pancreatitis, gallbladder problems, and kidney issues. Your provider will discuss all risks and monitor you during treatment. Visit our [Patient Education section](/education) for detailed guides on managing common side effects.
How long is the treatment?
Treatment duration is determined by your healthcare provider based on your individual situation and response. Your provider will work with you to determine the appropriate treatment plan.
Who may be considered for GLP-1 treatment?
Eligibility is determined by a licensed healthcare provider based on a comprehensive medical evaluation. Generally, providers consider factors such as BMI, medical history, and other health conditions. Not everyone is a candidate for these medications.
How is the medication administered?
Both semaglutide and tirzepatide are administered as subcutaneous injections. Your provider will provide detailed instructions on proper administration technique and dosing schedule.
Ready to Get Started?
Complete a medical evaluation to see if you may be a candidate for provider-supervised GLP-1 treatment.
Begin EvaluationImportant Safety Information
- GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider
- Tell your provider if you have a history of pancreatitis, thyroid cancer, medullary thyroid carcinoma (MTC), or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- GLP-1 medications may cause serious side effects including pancreatitis, gallbladder problems, and kidney problems
- Do not use if you are pregnant or breastfeeding, or planning to become pregnant
- Common side effects include nausea, diarrhea, vomiting, constipation, and abdominal pain, which typically improve over time
- Report any unusual symptoms to your healthcare provider immediately, including severe stomach pain, vision changes, or rapid heartbeat
About Compounded Medications
- Fifty 410 provides compounded semaglutide and tirzepatide medications, which are NOT FDA-approved finished drug products
- Drug compounding is the practice of creating customized medications by pharmacies to meet individual patient needs
- Compounded medications are prepared by FDA-registered 503A and 503B compounding pharmacies in accordance with federal and state regulations
- Compounded medications have not undergone FDA review for safety, efficacy, or quality
- Individual results may vary. The information on this page is for educational purposes only and does not constitute medical advice
- Always consult with a qualified healthcare provider before starting any medication or treatment program
Legal Disclaimer: The compounded medications provided by Fifty 410 are NOT FDA-approved finished drug products. They are prepared by FDA-registered 503A and 503B compounding pharmacies in accordance with federal and state regulations. Compounded medications have not undergone FDA review for safety, efficacy, or quality.
Individual results may vary. This website is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any medication or treatment program.
References:
- National Academies of Sciences, Engineering, and Medicine. "The Clinical Utility of Compounded Bioidentical Hormone Therapy: A Review of Safety, Effectiveness, and Use." Chapter 3: Oversight of Compounded Drugs. National Academies Press, 2020. Available at: https://www.ncbi.nlm.nih.gov/books/NBK562888/